We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest Industry Insights

Industry Insight

A New Approach to T-Cell Therapy

In this interview with Bryan Kobel, CEO of TC Biopharm, we find out about gamma-delta T-cell therapy, including how it works, its applications and how TC Biopharm developed its pioneering gamma-delta treatment for acute myeloid leukemia.
Industry Insight

A Paradigm Shift in Sepsis Diagnostics

In this interview, Rolland Carlson, PhD, CEO of Immunexpress, discusses sepsis and the company’s FDA cleared SeptiCyte® RAPID test, as well as a take on the company’s differentiated value and outlook.
Industry Insight

Could Human Breast Milk Balance Your Gut Microbiome?

In this interview, Gregory J. McKenzie, PhD, discusses the impact of antibiotics, the introduction of new bacteria into the microbiome and the potential of human breast milk-based therapeutics.
Industry Insight

How Can BioPlatforms Support the mRNA “Revolution”

The science and medicine worlds are experiencing a new revolution, and this time the protagonist is the mRNA molecule. In this article, we explore why bioplatforms support this revolution.
Industry Insight

Monkeypox Outbreak in Non-Endemic Countries: A Cause for Concern?

Technology Networks learns about the "unusual" spread of the monkeypox virus in non-endemic countries, possible vaccination strategies against the virus and if there are effective treatments available.
Industry Insight

Unlocking the Functional Antibody Repertoire

Technology Networks learns about serum epitope repertoire analysis and some of the applications it could benefit, including cancer diagnostics and COVID-19 studies.
Industry Insight

The Benefits of Automation for Antibody Discovery Workflows

At the recent Bio-IT World 2022 conference, Andrew LeBeau, associate vice president of product integrations at Dotmatics, gave a talk on the benefits that automation can bring to antibody discovery workflows. We spoke with LeBeau to find out more about these benefits and how Dotmatics’ approach meets one of the key themes of the conference, FAIR data principles.
Industry Insight

How Can Wastewater Testing Predict COVID-19 Outbreaks?

Technology Networks spoke to Francisco Bizouarn, market development manager of the Digital Biology Group at Bio-Rad Laboratories, to find out how wastewater testing works and how it can anticipate a rise in cases of COVID-19 and the emergence of new variants.
Industry Insight

How Researchers Are Bringing Sustainability to Scientific Discovery

Research is advancing exciting areas of science at an unprecedented pace, but the disposable materials, powered equipment and shipping associated with experiments, sample storage and transport of reagents contribute to high energy consumption and significant waste. How are researchers bringing sustainability to scientific discovery?
Industry Insight

Treating C. diff Infection and More With Gut Microbiome Transplants

Technology Networks had the pleasure of speaking to Thomas Lendvay, CMO and co-founder of Tend about the current applications of gut microbiota transplants and how they could be used in future.
Advertisement